In last trading session, Ocugen Inc (NASDAQ:OCGN) saw 2.1 million shares changing hands with its beta currently measuring 4.19. Company’s recent per share price level of $0.74 trading at $0.02 or 2.78% at ring of the bell on the day assigns it a market valuation of $215.18M. That closing price of OCGN’s stock is at a discount of -178.38% from its 52-week high price of $2.06 and is indicating a premium of 31.08% from its 52-week low price of $0.51. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.32 million shares which gives us an average trading volume of 3.84 million if we extend that period to 3-months.
For Ocugen Inc (OCGN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.06 in the current quarter.
Ocugen Inc (NASDAQ:OCGN) trade information
Upright in the green during last session for gaining 2.78%, in the last five days OCGN remained trading in the green while hitting it’s week-highest on Wednesday, 04/23/25 when the stock touched $0.74 price level, adding 1.32% to its value on the day. Ocugen Inc’s shares saw a change of -8.46% in year-to-date performance and have moved 12.81% in past 5-day. Ocugen Inc (NASDAQ:OCGN) showed a performance of 3.11% in past 30-days. Number of shares sold short was 65.79 million shares which calculate 15.53 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 5 to the stock, which implies a rise of 85.2% to its current value. Analysts have been projecting 3.5 as a low price target for the stock while placing it at a high target of 6. It follows that stock’s current price would drop -372.97% in reaching the projected high whereas dropping to the targeted low would mean a loss of -372.97% for stock’s current value.
Ocugen Inc (OCGN) estimates and forecasts
This year revenue growth is estimated to fall -100.00% from the last financial year’s standing.
Company posted 1.01M and 1.14M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 32.82% during past 5 years.
Ocugen Inc (NASDAQ:OCGN)’s Major holders
Insiders are in possession of 1.27% of company’s total shares while institution are holding 24.75 percent of that, with stock having share float percentage of 25.07%. Investors also watch the number of corporate investors in a company very closely, which is 24.75% institutions for Ocugen Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at OCGN for having 17.92 million shares of worth $27.78 million. And as of 2024-06-30, it was holding 6.9632 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 15.52 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.0311 of outstanding shares, having a total worth of $24.06 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 9.07 shares of worth $6.69 million or 3.11% of the total outstanding shares. The later fund manager was in possession of 7.54 shares on Mar 31, 2025 , making its stake of worth around $5.56 million in the company or a holder of 2.58% of company’s stock.
